Vertex Pharmaceuticals Inc
Close on Nov 20, 2026Market cap $130.54BP/E 30.0Yield –
Retained earnings (accumulated deficit) của Vertex Pharmaceuticals theo quý
Retained earnings (accumulated deficit) ($M) ($M)
Retained earnings (accumulated deficit) của Vertex Pharmaceuticals: $15,691M trong Q2 2026, tăng 39.0% so với cùng kỳ năm trước. Đó là mức cao nhất trong 67 quý có ở đây.
Số của Q2 2026 lấy từ đâu
Nguồn: Form 10-Q (filed 2026-08-04) ↗
Được báo cáo trong Form 10-Q / 10-K (DB).
Lịch sử theo quý
Rê chuột vào một số để xem câu chữ đã đọc ra số đó; số tự tính sẽ hiện công thức
| Kỳ | Kết thúc | Retained earnings (accumulated deficit) ($M) ($M) | So với cùng kỳ | Nguồn |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 15,691 | +39.0% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2026 | Mar 31, 2026 | 14,591 | +42.3% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2025 | Dec 31, 2025 | 13,560 | +41.2% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2025 | Sep 30, 2025 | 12,369 | +42.3% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 30, 2025 | 11,286 | +47.6% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 10,253 | -8.8% | Form 10-Q (filed 2025-05-06) ↗ |
| Q4 2024 | Dec 31, 2024 | 9,607 | -5.3% | Form 10-K (filed 2025-02-13) ↗ |
| Q3 2024 | Sep 30, 2024 | 8,694 | -5.2% | Form 10-Q (filed 2024-11-05) ↗ |
| Q2 2024 | Jun 30, 2024 | 7,648 | -6.0% | Form 10-Q (filed 2024-08-02) ↗ |
| Q1 2024 | Mar 31, 2024 | 11,242 | +55.7% | Form 10-Q (filed 2024-05-07) ↗ |
| Q4 2023 | Dec 31, 2023 | 10,142 | +55.5% | Form 10-K (filed 2024-02-15) ↗ |
| Q3 2023 | Sep 30, 2023 | 9,174 | +60.8% | Form 10-Q (filed 2023-11-07) ↗ |
| Q2 2023 | Jun 30, 2023 | 8,138 | +70.5% | Form 10-Q (filed 2023-08-02) ↗ |
| Q1 2023 | Mar 31, 2023 | 7,223 | +82.3% | Form 10-Q (filed 2023-05-02) ↗ |
| Q4 2022 | Dec 31, 2022 | 6,523 | +103.8% | Form 10-K (filed 2023-02-10) ↗ |
| Q3 2022 | Sep 30, 2022 | 5,704 | +134.7% | Form 10-Q (filed 2022-10-28) ↗ |
| Q2 2022 | Jun 30, 2022 | 4,773 | +202.4% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 3,963 | +162.1% | Form 10-Q (filed 2022-05-06) ↗ |
| Q4 2021 | Dec 31, 2021 | 3,201 | +272.7% | Form 10-K (filed 2022-02-09) ↗ |
| Q3 2021 | Sep 30, 2021 | 2,431 | +855.1% | Form 10-Q (filed 2021-11-03) ↗ |
| Q2 2021 | Jun 30, 2021 | 1,579 | -482.3% | Form 10-Q (filed 2021-07-30) ↗ |
| Q1 2021 | Mar 31, 2021 | 1,512 | -220.9% | Form 10-Q (filed 2021-04-30) ↗ |
| Q4 2020 | Dec 31, 2020 | 859 | -146.3% | Form 10-K (filed 2022-02-09) ↗ |
| Q3 2020 | Sep 30, 2020 | 255 | -110.4% | Form 10-Q (filed 2020-10-30) ↗ |
| Q2 2020 | Jun 30, 2020 | -413 | -83.4% | Form 10-Q (filed 2020-07-31) ↗ |
| Q1 2020 | Mar 31, 2020 | -1,250 | -54.7% | Form 10-Q (filed 2020-05-01) ↗ |
| Q4 2019 | Dec 31, 2019 | -1,853 | -38.0% | Form 10-K (filed 2020-02-13) ↗ |
| Q3 2019 | Sep 30, 2019 | -2,436 | -46.3% | Form 10-Q (filed 2019-10-31) ↗ |
| Q2 2019 | Jun 30, 2019 | -2,494 | -46.6% | Form 10-Q (filed 2019-08-01) ↗ |
| Q1 2019 | Mar 31, 2019 | -2,761 | -43.4% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | -2,990 | -41.6% | Form 10-K (filed 2019-02-13) ↗ |
| Q3 2018 | Sep 30, 2018 | -4,540 | -13.0% | Form 10-Q (filed 2018-10-25) ↗ |
| Q2 2018 | Jun 30, 2018 | -4,669 | -8.8% | Form 10-Q (filed 2018-07-26) ↗ |
| Q1 2018 | Mar 31, 2018 | -4,876 | -5.1% | Form 10-Q (filed 2018-04-27) ↗ |
| Q4 2017 | Dec 31, 2017 | -5,120 | -4.7% | Form 10-K (filed 2018-02-15) ↗ |
| Q3 2017 | Sep 30, 2017 | -5,220 | -3.4% | Form 10-Q (filed 2017-10-30) ↗ |
| Q2 2017 | Jun 30, 2017 | -5,118 | -4.7% | Form 10-Q (filed 2017-07-28) ↗ |
| Q1 2017 | Mar 31, 2017 | -5,136 | -3.2% | Form 10-Q (filed 2017-04-28) ↗ |
| Q4 2016 | Dec 31, 2016 | -5,374 | +2.1% | Form 10-K (filed 2017-02-23) ↗ |
| Q3 2016 | Sep 30, 2016 | -5,407 | +4.2% | Form 10-Q (filed 2016-10-31) ↗ |
| Q2 2016 | Jun 30, 2016 | -5,368 | +5.4% | Form 10-Q (filed 2016-08-01) ↗ |
| Q1 2016 | Mar 31, 2016 | -5,303 | +8.1% | Form 10-Q (filed 2016-05-03) ↗ |
| Q4 2015 | Dec 31, 2015 | -5,262 | +11.8% | Form 10-K (filed 2016-02-16) ↗ |
| Q3 2015 | Sep 30, 2015 | -5,188 | +14.6% | Form 10-Q (filed 2015-10-30) ↗ |
| Q2 2015 | Jun 30, 2015 | -5,093 | +16.8% | Form 10-Q (filed 2015-08-04) ↗ |
| Q1 2015 | Mar 31, 2015 | -4,904 | +16.8% | Form 10-Q (filed 2015-05-04) ↗ |
| Q4 2014 | Dec 31, 2014 | -4,705 | +18.6% | Form 10-K (filed 2015-02-13) ↗ |
| Q3 2014 | Sep 30, 2014 | -4,529 | +12.9% | Form 10-Q (filed 2014-11-06) ↗ |
| Q2 2014 | Jun 30, 2014 | -4,359 | +12.1% | Form 10-Q (filed 2014-07-31) ↗ |
| Q1 2014 | Mar 31, 2014 | -4,199 | +9.6% | Form 10-Q (filed 2014-05-05) ↗ |
| Q4 2013 | Dec 31, 2013 | -3,967 | +12.6% | Form 10-K (filed 2014-02-11) ↗ |
| Q3 2013 | Sep 30, 2013 | -4,011 | +16.4% | Form 10-Q (filed 2013-11-07) ↗ |
| Q2 2013 | Jun 30, 2013 | -3,887 | +14.7% | Form 10-Q (filed 2013-08-02) ↗ |
| Q1 2013 | Mar 31, 2013 | -3,830 | +15.2% | Form 10-Q (filed 2013-05-08) ↗ |
| Q4 2012 | Dec 31, 2012 | -3,522 | +3.1% | Form 10-K (filed 2013-03-01) ↗ |
| Q3 2012 | Sep 30, 2012 | -3,446 | -3.6% | Form 10-Q (filed 2012-11-06) ↗ |
| Q2 2012 | Jun 30, 2012 | -3,388 | -10.7% | Form 10-Q (filed 2012-08-08) ↗ |
| Q1 2012 | Mar 31, 2012 | -3,323 | -8.2% | Form 10-Q (filed 2012-05-10) ↗ |
| Q4 2011 | Dec 31, 2011 | -3,415 | -0.9% | Form 10-K (filed 2012-02-22) ↗ |
| Q3 2011 | Sep 30, 2011 | -3,574 | +9.5% | Form 10-Q (filed 2011-11-03) ↗ |
| Q2 2011 | Jun 30, 2011 | -3,795 | +24.2% | Form 10-Q (filed 2011-08-09) ↗ |
| Q1 2011 | Mar 31, 2011 | -3,621 | +26.8% | Form 10-Q (filed 2011-05-06) ↗ |
| Q4 2010 | Dec 31, 2010 | -3,444 | +28.1% | Form 10-K (filed 2011-02-17) ↗ |
| Q3 2010 | Sep 30, 2010 | -3,264 | – | Form 10-Q (filed 2010-10-28) ↗ |
| Q2 2010 | Jun 30, 2010 | -3,055 | – | Form 10-Q (filed 2010-08-03) ↗ |
| Q1 2010 | Mar 31, 2010 | -2,855 | – | Form 10-Q (filed 2010-05-03) ↗ |
| Q4 2009 | Dec 31, 2009 | -2,690 | – | Form 10-Q (filed 2010-05-03) ↗ |
Trích dẫn dữ liệu này
StockData. (2026). Retained earnings (accumulated deficit) ($M) của Vertex Pharmaceuticals, theo quý Q4 2009–Q2 2026 [Bộ dữ liệu]. Tổng hợp từ Hồ sơ SEC và tài liệu dành cho nhà đầu tư của Vertex Pharmaceuticals. https://stockdatahq.com/stocks/vrtx/kpis/fs-re
Xem mọi chỉ số ở bảng KPI của Vertex Pharmaceuticals. Dữ liệu cập nhật Nov 2, 2026.
See a number that looks wrong?